Novartis AG (NVS) stock surged +3.74%, trading at $159.90 on NYSE, up from the previous close of $154.14. The stock opened at $157.50, fluctuating between $157.01 and $160.57 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 02, 2026 | 157.50 | 160.57 | 157.00 | 159.90 | 1.55M |
| Jul 01, 2026 | 154.67 | 155.02 | 153.22 | 154.14 | 1.89M |
| Jun 30, 2026 | 157.63 | 157.89 | 155.92 | 156.72 | 1.76M |
| Jun 29, 2026 | 156.14 | 157.73 | 155.79 | 157.59 | 2.26M |
| Jun 26, 2026 | 153.33 | 156.38 | 153.33 | 155.41 | 3.83M |
| Jun 25, 2026 | 153.48 | 155.85 | 153.42 | 155.12 | 3.95M |
| Jun 24, 2026 | 154.20 | 154.96 | 152.30 | 153.12 | 7.22M |
| Jun 23, 2026 | 151.94 | 153.47 | 151.35 | 153.38 | 1.4M |
| Jun 22, 2026 | 146.94 | 149.23 | 146.60 | 148.93 | 1.29M |
| Jun 18, 2026 | 149.90 | 150.08 | 146.92 | 147.08 | 1.87M |
| Jun 17, 2026 | 151.42 | 152.57 | 150.20 | 150.88 | 1.66M |
| Jun 16, 2026 | 150.46 | 151.38 | 148.64 | 150.93 | 1.58M |
| Jun 15, 2026 | 153.07 | 153.32 | 151.26 | 151.56 | 1.66M |
| Jun 12, 2026 | 153.93 | 154.22 | 152.85 | 153.07 | 1.15M |
| Jun 11, 2026 | 152.00 | 154.71 | 151.62 | 153.92 | 2.1M |
| Jun 10, 2026 | 149.03 | 149.72 | 147.91 | 148.12 | 1.43M |
| Jun 09, 2026 | 147.19 | 149.71 | 147.04 | 149.12 | 2.39M |
| Jun 08, 2026 | 147.54 | 148.53 | 146.39 | 146.42 | 2.56M |
| Jun 05, 2026 | 147.65 | 149.16 | 147.44 | 149.16 | 3.48M |
| Jun 04, 2026 | 146.46 | 148.48 | 146.46 | 148.40 | 2.49M |
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
| Employees | 75511 |
| Beta | 0.49 |
| Sales or Revenue | $51.72B |
| 5Y Sales Change% | -0.026% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep